In a recently published study, Finnish researcher Jari Tiihonen and colleagues have concluded, based on their examination of a prescription data base, that first-episode schizophrenia patients who take antipsychotics continuously have lower mortality rates and lower risk of being rehospitalized than those who discontinue the drugs. Joanna Moncrieff and Sandy Steingard investigate the findings.
20-year Outcomes for First-episode Psychosis: Impact of Neuroleptic Drug Discontinuation
by Sandra Steingard, MD
A Commentary on the Finnish Analysis of Outcomes of First Episode Schizophrenia
by Joanna Moncrieff, MD
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.